Objective: Visfatin, a novel adipokine, was revealed to be associated with obesity and to have insulinmimetic effect. Eotaxin, which is an important chemokine in asthma, was recently reported to be associated with obesity in mice and humans. We evaluated the effect of exercise training on plasma visfatin and eotaxin levels in association with cardiovascular risk factors. Design: Forty-eight non-diabetic Korean women were evaluated before and after a 12 week exercise program including aerobic exercise (45 min/session, 300 Kcal/day) and muscle strength training (20 min/session, 100 Kcal/day) five times per week. Results: Plasma visfatin concentrations were elevated in obese subjects (body mass index, BMIR25 kg/m 2 ) when compared with non-obese subjects (16.4G13.4 ng/ml vs 7.7G 5.2 ng/ml, PZ0.006), and eotaxin concentrations were elevated in subjects with central obesity (waist circumference, WCR80 cm) when compared with those without central obesity (73.6G17.8 pg/ml vs 64.2G4.2 pg/ml, PZ0.005). In multiple regression analyses, visfatin levels were associated with BMI (R 2 Z0.255) and eotaxin levels were associated with WC and body weight (R 2 Z0.307). After the exercise program, body weight, blood pressure, fasting glucose, and insulin resistance of participants were decreased. Furthermore, plasma visfatin levels were significantly decreased from 13.6G12.0 to 7.7G7.9 ng/ml (PZ0.026) and eotaxin levels were reduced from 72.0G16.7 to 66.9G14.2 pg/ml (PZ0.018). Conclusions: Exercise training with weight loss induced a significant reduction of plasma visfatin and eotaxin levels in non-diabetic Korean women.European Journal of Endocrinology 157 437-442
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.